Directorate Change

RNS Number : 4882J
Assura PLC
03 April 2018
 

 

3 April 2018

 

Assura plc

 

Directorate Change

 

Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, confirms that, further to the announcement made on 3 October 2017, Andrew Darke stepped down from the Board effective 31 March 2018.

 

The remuneration disclosures required pursuant to section 430(2B) of the Companies Act 2006 will be available on the Company's website as soon as amounts have been finalised.

 

 

 

- Ends -

 

For more information, please contact:

 

Assura plc

 

Tel: 01925 420660

Orla Ball

 


 

Edelman

John Kiely

 

 

Tel: 0203 047 2546

Mav Wynn


Rob Yates

 


 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 30 September 2017, Assura's property portfolio was valued at £1.56 billion.

 

 

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPGUCWWUPRGAB

Companies

Assura (AGR)
UK 100

Latest directors dealings